Europe Acne Medication Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - by Therapeutic Class (Retinoids, Benzoyl Peroxide, Antibiotics, Salicylic Acid, and Others), Formulation (Topical Medication and Oral Medication), Type (Prescription Medicine and Over-the-Counter Medicine), Acne Type (Non-Inflammatory Acne and Inflammatory Acne), and Distribution Channel (Pharmacies and Drug Stores, Retail Stores, and E-Commerce)


No. of Pages: 127    |    Report Code: BMIRE00030657    |    Category: Life Sciences

Europe Acne Medication Market
Buy Now

The Europe acne medication market was valued at US$ 1,963.08 million in 2022 and is expected to reach US$ 3,112.69 million by 2030; it is estimated to register at a CAGR of 6.0% from 2023 to 2030.

Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies Drive Europe Acne Medication Market



Adopting advanced technologies and data-driven approaches in the Europe acne medication market opens up new avenues for research and development. By collecting and analyzing patient data, researchers can gain valuable insights into the underlying causes of acne, identify patterns and trends in treatment responses, and discover new potential targets for therapeutic interventions. This can drive the development of novel medications, innovative treatment strategies, and more personalized skincare products tailored to the diverse needs of acne patients. By leveraging artificial intelligence (AI), machine learning algorithms, genetic testing, and other cutting-edge tools, healthcare providers can now analyze vast data to gain a better understanding of patient's unique skin conditions, genetic predispositions, lifestyle factors, and treatment responses. This personalized approach allows for the development of tailored treatment plans specifically designed to address each patient's individual needs.

In March 2021, Onegevity, a health intelligence firm and a subsidiary of Thorne HealthTech, teamed up with Unilever, one of the top manufacturers of beauty and personal care products worldwide, to enable a more personalized approach to acne intervention and treatment. The scientific collaboration is meant to investigate the potential of multi-omics, or the integration of different biological disciplines, to enable more individualized approaches to treating acne. The collaboration aims to create new diagnostic models that can unlock customized acne treatment plans by utilizing Onegevity's AI and machine learning capabilities that allow the evaluation of billions of biological characteristics affecting a person's health. Personalized treatment plans help to optimize treatment efficacy by taking into account patients' specific characteristics and factors that may influence their response to acne medication. Based on such patient-specific data, healthcare providers can prescribe treatments that are more likely to be effective for that particular individual. This improves the chances of successfully treating acne and reduces the likelihood of side effects and adverse reactions, leading to better patient outcomes and increased satisfaction. Thus, integrating advanced technologies and data-driven approaches for designing personalized treatment plans creates significant opportunities for innovation, growth, and improved patient outcomes in the Europe acne medication market.

Europe Acne Medication Market Overview



Europe ranks second in the global acne medication market. It is further anticipated to register a significant CAGR during the forecast period. The acne medication market growth in the region is ascribed to the increasing prevalence of acne and the growing presence of major players. The research-based pharmaceutical industry can play a key role in supporting the acne medication market growth in Europe and ensuring its future competitiveness in the global economy. Formel Skin, a Berlin-based business that is a pioneer in dermatology telehealth, announced the completion of a US$ 32.35 (30) million series fundraising round in January 2022. The funding was led by Singular and Heal Capital and supported by Cherry Ventures, Heartcore Capital, and Vorwerk Ventures. With this funding, the company plans to undertake the long-term development and expansion of its remote skincare platform.

Europe Acne Medication Market Revenue and Forecast to 2030 (US$ Million)

Get more information on this report

Europe Acne Medication Strategic Insights

Strategic insights for the Europe Acne Medication provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/europe-acne-medication-market-strategic-framework.webp
Get more information on this report

Europe Acne Medication Report Scope

Report Attribute Details
Market size in 2022 US$ 1,963.08 Million
Market Size by 2030 US$ 3,112.69 Million
Global CAGR (2023 - 2030) 6.0%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Therapeutic Class
  • Retinoids
  • Benzoyl Peroxide
  • Antibiotics
  • Salicylic Acid
By Formulation
  • Topical Medication and Oral Medication
By Acne Type
  • Non-Inflammatory Acne and Inflammatory Acne
By Distribution Channel
  • Pharmacies and Drug Stores
  • Retail Stores
  • E-Commerce
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Teva Pharmaceutical Industries Ltd
  • Almirall SA
  • Johnson & Johnson
  • Sun Pharmaceutical Industries Ltd
  • Bausch Health Companies Inc
  • Galderma SA
  • Pfizer Inc
  • GSK Plc
  • Viatris Inc
  • Pierre Fabre SA
  • Get more information on this report

    Europe Acne Medication Regional Insights

    The geographic scope of the Europe Acne Medication refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/europe-acne-medication-market-geography.webp
    Get more information on this report

    Europe Acne Medication Market Segmentation



    The Europe acne medication market is segmented based on therapeutic class, formulation, type, acne type, distribution channel, and country.

    Based on therapeutic class, the Europe acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held the largest share in 2022.

    In terms of formulation, the Europe acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held a larger largest share in 2022.

    By type, the Europe acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger largest share in 2022.

    Based on acne type, the Europe acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held a larger share in 2022.

    In terms of distribution channel, the Europe acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held the largest share in 2022.

    Based on country, the Europe acne medication market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe acne medication market in 2022.

    Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Galderma SA, Pfizer Inc, GSK Plc, Viatris Inc, and Pierre Fabre SA are some of the leading companies operating in the Europe acne medication market.

    The List of Companies - Europe Acne Medication Market

    1. Teva Pharmaceutical Industries Ltd

    2. Almirall SA

    3. Johnson & Johnson

    4. Sun Pharmaceutical Industries Ltd

    5. Bausch Health Companies Inc

    6. Galderma SA

    7. Pfizer Inc

    8. GSK Plc

    9. Viatris Inc

    10. Pierre Fabre SA

    Frequently Asked Questions
    How big is the Europe Acne Medication Market?

    The Europe Acne Medication Market is valued at US$ 1,963.08 Million in 2022, it is projected to reach US$ 3,112.69 Million by 2030.

    What is the CAGR for Europe Acne Medication Market by (2023 - 2030)?

    As per our report Europe Acne Medication Market, the market size is valued at US$ 1,963.08 Million in 2022, projecting it to reach US$ 3,112.69 Million by 2030. This translates to a CAGR of approximately 6.0% during the forecast period.

    What segments are covered in this report?

    The Europe Acne Medication Market report typically cover these key segments-

    • Therapeutic Class (Retinoids, Benzoyl Peroxide, Antibiotics, Salicylic Acid)
    • Formulation (Topical Medication and Oral Medication)
    • Acne Type (Non-Inflammatory Acne and Inflammatory Acne)
    • Distribution Channel (Pharmacies and Drug Stores, Retail Stores, E-Commerce)

    What is the historic period, base year, and forecast period taken for Europe Acne Medication Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Acne Medication Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Europe Acne Medication Market?

    The Europe Acne Medication Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Teva Pharmaceutical Industries Ltd
  • Almirall SA
  • Johnson & Johnson
  • Sun Pharmaceutical Industries Ltd
  • Bausch Health Companies Inc
  • Galderma SA
  • Pfizer Inc
  • GSK Plc
  • Viatris Inc
  • Pierre Fabre SA
  • Who should buy this report?

    The Europe Acne Medication Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Acne Medication Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    europe-acne-medication-market